Severe infections in Portuguese patients with rheumatoid arthritis under biologic treatment - a multicenter, nationwide study (SIPPRA-B Study).

Filipe Oliveira Pinheiro,Maria Seabra Rato,Pedro Madureira,Filipe Araújo,Maria João Salvador, Vanessa Fraga,Luisa Brites,Filipe Cunha Santos,Augusto Silva, Ana Rita Lopes, Margarida Cruz, João Paulo Vilas Boas, Maria Pontes Ferreira,Beatriz Samões, Tiago Beirão,Inês Santos, Daniel Carvalho,Lúcia Costa,Miguel Bernardes

ARP rheumatology(2023)

引用 0|浏览1
暂无评分
摘要
This study described the incidence and types of SI among Portuguese RA patients on biologics, identifying several predictors of SI, both globally and with different bDMARDs. Physicians should be aware of the real-word infectious risk in RA patients on bDMARDs when making treatment decisions.
更多
查看译文
关键词
Rheumatoid arthritis, Immunosuppressants, Biological therapies, DMARDs
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要